Find Federal Grants
Health Resources and Services Administration · HRSA-22-083
Advancing Integrated Models (AIM) of Care to Improve Maternal Health Outcomes among Women Who Experience Persistent Disparities (R21 Clinical Trial Optional)
National Institutes of Health · RFA-NR-22-003
Notice of Intent to Publish Funding Opportunity Announcements for the RADx?-UP Initiative (Phase III)
National Institutes of Health · NOT-OD-22-051
Advancing Integrated Models (AIM) of Care to Improve Maternal Health Outcomes among Women Who Experience Persistent Disparities (R01 Clinical Trial Required)
National Institutes of Health · RFA-NR-22-002
National Institutes of Health · PAR-22-078
Notice of Intent to Publish a Funding Opportunity Announcement for Advancing Integrated Models (AIM) of Care to Improve Maternal Health Outcomes among Women Who Experience Persistent Disparities (R21 Clinical Trial Optional)
National Institutes of Health · NOT-NR-22-003
Notice of Intent to Publish a Funding Opportunity Announcement for Biomedical-engineering Partnership with Industry (U01 Clinical Trial Not Allowed)
National Institutes of Health · NOT-EB-21-024
Evaluating the Impact of COVID-19 Pandemic-related Food and Housing Policies and Programs on Health Outcomes in Health Disparity Populations (R01 Clinical Trial Optional)
National Institutes of Health · RFA-NR-22-001
BRAIN Initiative: Development of Novel Tools to Probe Cell-Specific and Circuit-Specific Processes in Human and Non-Human Primate Brain (UG3/UH3 Clinical Trial Optional)
National Institutes of Health · RFA-MH-22-115
Tribal Management Grant Program
Indian Health Service · HHS-2022-IHS-TMD-0001
Investigation of Monkeypox and Other Zoonotic Diseases in the Democratic Republic of the Congo (DRC)
Centers for Disease Control and Prevention - ERA · RFA-CK-22-001
Catalyze: Product Definition Device Prototype Design and Testing, Diagnostic Disease Target Identification and Assay Development, and Research Tool Development (R61/R33 - Clinical Trial Not Allowed)
National Institutes of Health · RFA-HL-23-013
Catalyze: Product Definition for Small Molecules and Biologics - Preliminary Product/Lead Series Identification (R33 - Clinical Trial Not Allowed)
National Institutes of Health · RFA-HL-23-012
Catalyze: Product Definition Device Prototype Testing and Design Modification, Diagnostic Disease Target Assay Development and Design Characterization, and Research Tool Testing and Validation (R33 - Clinical Trials Not Allowed)
National Institutes of Health · RFA-HL-23-014
National Institutes of Health · RFA-MH-22-155
Catalyze: Product Definition for Small Molecules and Biologics - Target Identification and Validation, and Preliminary Product/Lead Series Identification (R61/R33 Clinical Trials Not Allowed)
National Institutes of Health · RFA-HL-23-011
Catalyze: Enabling Technologies and Transformative Platforms for HLBS Research (R33 - Clinical Trials Not Allowed)
National Institutes of Health · RFA-HL-23-010
ARDS, Pneumonia, and Sepsis Phenotyping Consortium Coordinating Center (U01 Clinical Trial Not Allowed)
National Institutes of Health · RFA-HL-23-002
ARDS, Pneumonia, and Sepsis Phenotyping Consortium Clinical Centers (U01 Clinical Trial Not Allowed)
National Institutes of Health · RFA-HL-23-001
Advancing Research on Mechanisms and Management of Pain for Diseases and Conditions within NIDDK Mission Areas (R01 Clinical Trial Optional)
National Institutes of Health · RFA-DK-22-005